Driving Under the Influence of Amphetamine-Like Drugs

Journal of Forensic Sciences

Volumn 57, Issue 2, 2012, Pages 413-419

  Musshoff, Frank ^a   Madea, Burkhard ^a  

^a Institute of Forensic Medicine   (Germany)

Author keywords

Amphetamines; Driving ability; Driving under the influence of drugs; Ecstasy; Exhaustion; Forensic science; Gas chromatography mass spectrometry

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID; COCAINE; METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; BLOOD; CAR DRIVING; DRUG ABUSE; FEMALE; FORENSIC TOXICOLOGY; HUMAN; LEGAL ASPECT; MALE; MASS FRAGMENTOGRAPHY; SUBSTANCE ABUSE;

ADULT; AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; AUTOMOBILE DRIVING; BENZODIAZEPINES; CANNABINOIDS; COCAINE; FEMALE; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METHADONE; NARCOTICS; SUBSTANCE ABUSE DETECTION;

EID: 84857444961     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2012.02055.x     Document Type: Article

References (62)

1. Musshoff F. Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine Drug Metab Rev 2000;32:15-44.
2. Kraemer T, Maurer HH. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. Ther Drug Monit 2002;24:277-89.
3. Staack RF, Maurer HH. Metabolism of designer drugs of abuse. Curr Drug Metab 2005;6:259-74.
4. Iten PX. Designer-Drogen vom Ecstasy-Typ. Wiesbaden, Germany: Abbott, 1998;31-8.
5. Maes V, Charlier C, Grenez O, Verstraete A. Rosita EU research project. Deliverable 1: drugs and medicines that are suspected to have a detrimental effect on road user performance, 1999;5-44, (accessed June 20, 2010).
6. Australian Drug Foundation. Drugs and driving, (accessed June 20, 2010).
7. Austrian Road Safety Board. Preventative measures to prevent driving while under the influence of alcohol/drugs. Wien, Austria: Kuratorium für Verkehrssicherheit, 2003.
8. Raes E, van den Neste T, Verstraete A, Lopez D, Hughes B, Griffiths P. Drug use, impaired driving and traffic accidents. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2008.
9. Madea B, Dettmeyer R, with collaboration of Musshoff F. Basiswissen Rechtsmedizin. Heidelberg, Germany: Springer Verlag, 2007.
10. Madea B, Musshoff F, Berghaus G. Verkehrsmedizin. Cologne, Germany: Deutscher Ärzteverlag, 2007.
11. Silber BY, Papafotiou K, Croft RJ, Ogden E, Swann P, Stough C. The effects of dexamphetamine on simulated driving performance. Psychopharmacology (Berl) 2005;179:536-43.
12. Brookhuis KA, de Waard D, Samyn N. Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology (Berl) 2004;173:440-5.
13. Gustavsen I, Mørland J, Bramness JG. Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers. Accid Anal Prev 2006;38:490-5.
14. Dussault C, Brault M, Bouchard J, Lemire AM. The contribution of alcohol and other drugs among fatally injured drivers in Québec: some preliminary results. Proceedings of the 16th International Conference on Alcohol, Drugs, and Traffic Safety; 2002 Aug 4-9; Montreal, Canada: La Societe deI'Assurance Automobile du Quebec, 2002.
15. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 2004;36:239-48.
16. Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, et al. Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 2003;17:379-87.
17. Ramaekers JG, Kuypers KP, Samyn N. Stimulant effects of 3, 4-methylenedioxymethamphetamine (MDMA) 75mg and methylphenidate 20mg on actual driving during intoxication and withdrawal. Addiction 2006;101:1614-21.
18. Kuypers KP, Wingen M, Samyn N, Limbert N, Ramaekers JG. Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology (Berl) 2007;192:111-9.
19. Kuypers KP, Samyn N, Ramaekers JG. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function. Psychopharmacology (Berl) 2006;187:467-75.
20. Ramaekers JG, Kuypers KP. Acute effects of 3, 4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 2006;31:1048-55.
21. Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci Int 2007;165:216-24.
22. Society of Toxicological and Forensic Chemistry (GTFCh). Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen und Anforderungen an die Validierung von Analysenmethoden, (accessed June 20, 2010).
23. Longo MC, Hunter CE, Lokan RJ, White JM, White MA. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000;32:623-32.
24. Kintz P, Cirimele V, Mairot F, Muhlmann M, Ludes B. Drug tests on 198 drivers involved in an accident. Presse Med 2000;29:1275-8.
25. Mura P, Kintz P, Ludes B, Gaulier JM, Marquet P, Martin-Dupont S, et al. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int 2003;133:79-85.
26. Michael WJ, Flegel R, Atkins R, Cangianelli LA, Cooper C, Welsh C, et al. Drug and alcohol use among drivers admitted to a Level-1 trauma center. Accid Anal Prev 2005;37:894-901.
27. Dussault C, Brault M, Bouchard J, Lemire AM. The contribution of alcohol and other drugs among fatally injured drivers in Québec: final results. In: Oliver J, Williams P, Clayton A, editors. Proceedings of the 17th International Conference on Alcohol, Drugs, and Traffic Safety; 2004 Aug 8-13; Glasgow, Scotland. Ann Arbor, MI: The International Council on Alcohol, Drugs and Traffic Safety, 2004.
28. Mura P, Chatelain C, Dumestre V, Gaulier JM, Ghysel MH, Lacroix C, et al. Use of drugs of abuse in less than 30-year-old drivers killed in a road crash in France: a spectacular increase for cannabis, cocaine and amphetamines. Forensic Sci Int 2006;160:168-72.
29. Vignali C, Groppi A, Polettini A, Valli A, Sali A, Cancelli B, Montagna M. Drugs and driving. Toxicological findings in 119 fatally injured drivers. In: Novakova E, Habrdova V, editors. Proceedings of the 39th International Meeting of the International Association of Forensic Toxicologists (TIAFT); 2001 Aug 26-30; Prague, Czech Republic: Faculty of Medicine Charles University, 2001;368-73.
30. Soderstrom CA, Ballesteros MF, Dischinger PC, Kerns TJ, Flint RD, Smith GS. Alcohol/drug abuse, driving convictions, and risk-taking dispositions among trauma center patients. Accid Anal Prev 2001;33:771-82.
31. del Rio CM, Gomez J, Sancho M, Alvarez FJ. Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000. Forensic Sci Int 2002;127:63-70.
32. Holmgren P, Holmgren A, Ahlner J. Alcohol and drugs in drivers fatally injured in traffic accidents in Sweden during the years 2000-2002. Forensic Sci Int 2005;151:11-7.
33. Assum T, Mathijssen MPM, Houwing S. The prevalence of drug driving and relative risk estimations. A study conducted in the Netherlands, Norway and United Kingdom; immortal deliverable D-R4.2. Vienna, Austria: Austrian Road Safety Board, 2005.
34. Logan BK, Schwilke EW. Changing patterns of alcohol and drug use in fatally injured drivers in Washington State 1992-2002. In: Oliver J, Williams P, Clayton A, editors. Proceedings of the 17th International Conference on Alcohol, Drugs, and Traffic Safety; 2004 Aug 8-13; Glasgow, Scotland. Ann Arbor, MI: The International Council on Alcohol, Drugs and Traffic Safety, 2004.
35. Logan BK. Adverse effects of stimulants and cannabis on driving. 17th Triennial Meeting of the International Association of Forensic Sciences (IAFS); 2005 Aug 21-26; Hong Kong. Hong Kong: IAFS, 2005.
36. Augsburger M, Donze N, Menetrey A, Brossard C, Sporkert F, Giroud C, et al. Concentration of drugs in blood of suspected impaired drivers. Forensic Sci Int 2005;153:11-5.
37. Gjerde H, Normann PT, Pettersen BS, Assum T, Aldrin M, Johansen U, et al. Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. Accid Anal Prev 2008;40:1765-72.
38. Senna MC, Augsburger M, Aebi B, Briellmann TA, Donzé N, Dubugnon JL, et al. First nationwide study on driving under the influence of drugs in Switzerland. Forensic Sci Int 2010;198:11-6.
39. Kotsos A, Gerostamoulos J, Boorman M, Drummer OH. Prevalence of drugs in Victorian impaired drivers. Proceedings of the 41st Meeting of the International Association of Forensic Toxicologists (TIAFT); 2003 Nov 16-20; Melbourne, Australia. Melbourne, Australia: TIAFT, 2003.
40. Raes E, Verstraete AG. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID). J Anal Toxicol 2005;29:632-6.
41. Smink BE, Ruiter B, Lusthof KJ, Zweipfenning PG. Driving under the influence of alcohol and/or drugs in the Netherlands 1995-1998 in view of the German and Belgian legislation. Forensic Sci Int 2001;120:195-203.
42. Christophersen AS. The occurence of drugged driving in Norway-existing problems and solutions. Blutalkohol 2000;37:20-7.
43. Toennes SW, Kauert GF, Steinmeyer S, Moeller MR. Driving under the influence of drugs-evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int 2005;152:149-55.
44. Wollersen H, Müller C, Musshoff F, Madea B. Drogen- und Arzneimittelbeeinflussung von Verkehrsteilnehmern. Blutalkohol 2008;45:89-102.
45. Jones AW. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances. Traffic Inj Prev 2005;6:317-22.
46. Maes V, Samyn N, Willekens M, De Boeck G, Verstraete A. 'Stupefiants et conduite automobile - les actions realisees en Belgique.' Ann Toxicol Analyt 2003;15:128-37.
47. Nemecek D. Amphetamin- und Amphetaminderivat-Konsum und Teilnahme am Straßenverkehr. Gibt es eine Beziehung zwischen Wirkung und Wirkstoffkonzentration im Blut? [Thesis]. Düsseldorf (Germany): Heinrich-Heine University, 2008.
48. Jones AW, Holmgren A. Abnormally high concentrations of amphetamine in blood of impaired drivers. J Forensic Sci 2005;50:1215-20.
49. Jones AW. Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment. Addiction 2007;102:1085-91.
50. Verschraagen M, Maes A, Ruiter B, Bosman IJ, Smink BE, Lusthof KJ. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases. Forensic Sci Int 2007;170:163-70.
51. Dresen S, Kempf J, Weinmann W. Prevalence of gamma-hydroxybutyrate (GHB) in serum samples of amphetamine, metamphetamine and ecstasy impaired drivers. Forensic Sci Int 2007;173:112-6.
52. Engblom C, Gunnar T, Rantanen A, Lillsunde P. Driving under the influence of drugs-amphetamine concentrations in oral fluid and whole blood samples. J Anal Toxicol 2007;31:276-80.
53. Moeller MR, Hartung M. Ecstasy and related substances-serum levels in impaired drivers. J Anal Toxicol 1997;21:591-6.
54. Hausken AM, Skurtveit S, Christophersen AS. Characteristics of drivers testing positive for heroin or ecstasy in Norway. Traffic Inj Prev 2004;5:107-11.
55. Jones AW, Holmgren A, Kugelberg FC. Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood. J Stud Alcohol Drugs 2008;69:202-8.
56. Samyn N, Viaene B, Laeremans G, De Boeck G, Maes V. First experience with the enforcement of the new per se DUID legislation in Belgium. In: Rasanen I, editor. Proceedings of the 38th Meeting of the International Association of Forensic Toxicologists (TIAFT); 2000 Aug 13-17; Helsinki, Finland. Helsinki, Finland: TIAFT, 2000;106-16.
57. Silber BY, Papafotiou K, Croft RJ, Stough CK. An evaluation of the sensitivity of the standardised field sobriety tests to detect the presence of amphetamine. Psychopharmacology (Berl) 2005;182:153-9.
58. Daldrup T. Neue Erkenntnisse zur Beurteilung der Blutbefunde. Blutalkohol 2008;45:S2-10.
59. Musshoff F, Wollersen H, Madea B. Über die Beeinträchtigung der Fahrsicherheit nach Konsum von Amphetaminen. In: Mattern R, editor. Kongressbericht der Deutschen Gesellschaft für Verkehrsmedizin e.V., Berichte der Bundesanstalt für straßenwesen, mensch und sicherheit, Heft M 195, Wirtschaftsverlag NW, Bremerhaven, 2008;157-60.
60. Schnabel A, Niess C, Kauert G. Die Erschöpfungsreaktion nach Amphetaminkonsum und ihre Auswirkungen auf die Fahrtüchtigkeit. Rechtsmed 2000;10:86-9.
61. Lemos NP. Methamphetamine and driving. Sci Justice 2009;49:247-9.
62. Ellinwood EH, Nikaido AM. Stimulant induced impairment: a perspective across dose and duration of use. Alco Drugs Driving 1987;3:19-24.